In Acute Myeloid Leukemia (AML), blasts exploit TNTs to import mitochondria from BMSCs, enhancing survival and metabolic fitness; this transfer is driven by NOX2-generated superoxide and amplified by chemotherapy, potentially fueling relapse. The gene discussed is CYBB; the disease is acute myeloid leukemia.